Schroder Investment Management Group raised its stake in INC Research Holdings, Inc. (NASDAQ:INCR) by 0.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 370,558 shares of the company’s stock after purchasing an additional 1,653 shares during the period. Schroder Investment Management Group owned 0.68% of INC Research Holdings worth $21,604,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Arizona State Retirement System bought a new stake in INC Research Holdings in the second quarter valued at $1,336,000. TradeLink Capital LLC bought a new stake in INC Research Holdings in the first quarter valued at $789,000. Bank of Montreal Can increased its stake in INC Research Holdings by 1.3% in the second quarter. Bank of Montreal Can now owns 95,837 shares of the company’s stock valued at $5,606,000 after purchasing an additional 1,198 shares in the last quarter. Redmile Group LLC bought a new stake in INC Research Holdings in the first quarter valued at $29,059,000. Finally, Alambic Investment Management L.P. increased its stake in INC Research Holdings by 301.9% in the first quarter. Alambic Investment Management L.P. now owns 42,600 shares of the company’s stock valued at $1,953,000 after purchasing an additional 32,000 shares in the last quarter. 98.97% of the stock is owned by hedge funds and other institutional investors.

In related news, CEO Alistair Macdonald sold 8,828 shares of the stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $55.65, for a total value of $491,278.20. Following the completion of the transaction, the chief executive officer now directly owns 110,629 shares in the company, valued at approximately $6,156,503.85. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Christopher L. Gaenzle sold 6,873 shares of the stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $58.32, for a total transaction of $400,833.36. Following the completion of the transaction, the chief accounting officer now owns 47,450 shares of the company’s stock, valued at $2,767,284. The disclosure for this sale can be found here. Over the last quarter, insiders sold 199,016 shares of company stock valued at $11,655,556. 0.24% of the stock is owned by company insiders.

Shares of INC Research Holdings, Inc. (INCR) opened at 55.00 on Wednesday. The company has a market capitalization of $2.98 billion, a P/E ratio of 33.70 and a beta of 1.41. INC Research Holdings, Inc. has a 52-week low of $40.65 and a 52-week high of $61.10. The stock’s 50 day moving average is $56.25 and its 200 day moving average is $52.39.

INC Research Holdings (NASDAQ:INCR) last posted its earnings results on Thursday, July 27th. The company reported $0.64 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.64. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The firm had revenue of $258.10 million during the quarter, compared to analysts’ expectations of $256.76 million. During the same period last year, the company posted $0.61 EPS. The company’s quarterly revenue was down .3% compared to the same quarter last year. Equities analysts expect that INC Research Holdings, Inc. will post $2.63 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This report was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/09/13/inc-research-holdings-inc-incr-shares-bought-by-schroder-investment-management-group.html.

Several equities research analysts have weighed in on INCR shares. TheStreet downgraded shares of INC Research Holdings from a “b” rating to a “c” rating in a research note on Friday, July 28th. Zacks Investment Research downgraded shares of INC Research Holdings from a “hold” rating to a “sell” rating in a research note on Tuesday, May 16th. BidaskClub downgraded shares of INC Research Holdings from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. KeyCorp raised shares of INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 price target for the company in a research note on Monday, June 5th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and issued a $62.00 price target on shares of INC Research Holdings in a research note on Friday, June 16th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $63.79.

INC Research Holdings Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for INC Research Holdings, Inc. (NASDAQ:INCR).

Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)

Receive News & Stock Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related stocks with our FREE daily email newsletter.